Grünenthal Company Profile
Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti Grünenthal sono commercializzati in oltre 80 Paesi e il numero delle filiali è in continua crescita. Grünenthal occupa circa 4.800 persone a livello mondiale, persone che hanno dato un grande contributo per il successo della Società.L'ulteriore consolidamento attraverso una ricerca innovativa è una parte integrante della politica della nostra Società. L'ambizione di Grünenthal è quella di essere una società leader nella Ricerca e Sviluppo in campi selezionati: l'area dolore è la nostra competenza core.
Location
Via Correggio, 43
Milano
20149
Italy
Contact
Phone: 39-02-43051
Fax: 39-02-430555
Email: dg@grunenthal.com
News Articles
Winners of EFIC-Grünenthal-Grant announced
For the 8th time the European Federation of IASP Chapters in cooperation with the pharmaceutical company Grünenthal Group announced the EFIC-Grünenthal-Grant (E-G-G) - a grant aimed to support young...
EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects
BRUSSELS and AACHEN, Germany , June 6, 2013 /- Supporting Young Scientists on the Subject of Pain Research For the 8 th time the European Federation of IASP® Chapters (EFIC®...
Grünenthal, Amura sign new research deal
The Grünenthal Group and Amura Therapeutics have entered into research deal focused on the areas of pain and inflammation.
Grünenthal and Vifor breach Code
Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts detailing their offences, including breaches of clause 2: ‘Bringing discred...
Grünenthal Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN)
AACHEN, Germany, May 22, 2013 /PRNewswire/ -- Healthcare professionals who would like to know more about the topical treatment of postherpetic neuralgia (PHN) can now find useful information online....
Grünenthal Appoints Oscar Ferenczi to Lead its Latin America Business
AACHEN, Germany, February 18, 2013 /PRNewswire/ -- Oscar Ferenczi, former Region Head of Sandoz Latin America, takes over responsibility for Grünenthal's Strategic Business Unit (SBU) LATAM. To...
Grünenthal and Vifor fall foul of ABPI Code
Grünenthal and Vifor fall foul of ABPI Code
Grünenthal Group and Purdue Pharma L.P. Enter Into a Licensing Agreement
AACHEN, Germany, May 28, 2013 /PRNewswire/ -- The Grünenthal Group announced today that they have entered into a licensing agreement with Purdue Pharma L.P. regarding certain intellectual proper...
Drugs and Medications
None
PubMed Articles
Spinal noradrenaline is thought to play an important role in descending pain inhibitory pathways and the modulation of nociceptive information at the spinal level. Tapentadol is a μ-opioid receptor (...
Analysis of TRPV1 gene polymorphisms in Spanish patients with neuropathic pain.
The vanilloid receptor TRPV1 is a molecular integrator of painful stimuli. Several recent studies suggest that TRPV1 may play a role in development and maintenance of chronic pain. In an attempt to de...
Chronic noncancer pain intensity is inversely related to analgesic adherence in pain clinics.
Abstract Objective: The relationship between chronic noncancer pain (CNCP) control and pain medication (analgesic) adherence has not been widely documented. The primary aim of this study was to evalua...
Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules.
Blockade of voltage-gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathological firing patterns that occur in conditions as diverse as chronic pain, epilep...
Clinical Trials
None
Companies
Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...
Nil
More Information about "Grünenthal" on BioPortfolio
We have published hundreds of Grünenthal news stories on BioPortfolio along with dozens of Grünenthal Clinical Trials and PubMed Articles about Grünenthal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal Companies in our database. You can also find out about relevant Grünenthal Drugs and Medications on this site too.
